NCT00146601View on ClinicalTrials.gov

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Breast Cancer
Interventions
DRUG

Fulvestrant

Trial Locations (4)

02115

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

01854

Lowell General Hospital, Lowell

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Lowell General Hospital

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00146601 - Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | Biotech Hunter | Biotech Hunter